Acer Therapeutics Inc. (ACER): Price and Financial Metrics
Acer Therapeutics Inc. (ACER)
Today's Latest Price: $3.33 USD
0.20 (6.39%)
Updated Nov 15 12:00am
Add ACER to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ACER Daily Price Range
ACER 52-Week Price Range
ACER Stock Price Chart More Charts
ACER Price/Volume Stats
| Current price | $3.33 |
| Prev. close | $3.13 |
| Day low | $3.16 |
| Day high | $3.34 |
| 50-day MA | $3.20 |
| 200-day MA | $12.06 |
| 52-week high | $28.25 |
| 52-week low | $1.87 |
| Volume | 40,700 |
| Avg. volume | 133,214 |
| Dividend yield | N/A |
| Market Cap | 33.62M |
Acer Therapeutics Inc. (ACER) Company Bio
Acer Therapeutics Inc., formerly Opexa Therapeutics, develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs. The company offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease. It also offers advancing ACER-001 for the treatment of urea cycle disorders. The company was founded in 2013 and is based in Cambridge, Massachusetts.
Top Stories View All
12 Stocks with 50%+ Upside
Best & Worst Performing Stock Industries for November 15, 2019
Best & Worst Performing Small Cap Stocks for November 15, 2019
Best & Worst Performing Mid Cap Stocks for November 15, 2019
Best & Worst Performing Large Cap Stocks for November 15, 2019
View All Top Stories
Loading social stream, please wait...